Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sim, Hao-Wen
477  Ergebnisse:
Personensuche X
?
1

Prognostic and predictive biomarkers in central nervous sys..:

Satgunaseelan, Laveniya ; Sy, Joanne ; Shivalingam, Brindha...
Pathology.  56 (2024)  2 - p. 158-169 , 2024
Link: https://doi.org/10.1016/..
 
?
2

'The Reports of My Death Are Greatly Exaggerated'—Evaluatin..:

Satgunaseelan, Laveniya ; Lee, Maggie ; Iannuzzi, Sebastian...
Cancers.  16 (2024)  10 - p. 1906 , 2024
Link: https://doi.org/10.3390/..
 
?
3

PATH-25. EXPLORING THE PROGNOSTIC IMPLICATIONS OF MOLECULAR..:

McNamee, Nicholas ; Lin, Frank ; Sim, Hao-Wen...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v173-v173 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Plasma Cetuximab Concentrations Correlate With Survival in ..:

Jiang, Di Maria ; Parshad, Shruti ; Zhan, Luna...
Clinical Colorectal Cancer.  22 (2023)  4 - p. 457-463 , 2023
Link: https://doi.org/10.1016/..
 
?
5

BRAF-mediated brain tumors in adults and children: A review..:

Trinder, Sarah M. ; McKay, Campbell ; Power, Phoebe...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
6

Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wil..:

Sim, Hao-Wen ; Lorrey, Selena ; Khasraw, Mustafa
Current Neurology and Neuroscience Reports.  23 (2023)  6 - p. 263-276 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Older age should not be a barrier to testing for somatic va..:

Pitiyarachchi, Omali ; Lee, Yeh Chen ; Sim, Hao-Wen...
Translational Oncology.  31 (2023)  - p. 101638 , 2023
Link: https://doi.org/10.1016/..
 
?
8

STEM-03. TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA:

Mason, Sofia ; Chung, Sylvia ; Juan, Beatriz Perez San...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v33-v33 , 2023
Link: https://doi.org/10.1093/..
 
?
9

NUTMEG: A randomized phase II study of nivolumab and temozo..:

Sim, Hao-Wen ; Wachsmuth, Luke ; Barnes, Elizabeth H...
Neuro-Oncology Advances.  5 (2023)  1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
10

Clinical Trials in the Brain Tumour Population: Challenges ..:

Gan, Hui Kong ; Day, Bryan W. ; Harrup, Rosemary...
Current Oncology Reports.  25 (2023)  6 - p. 589-598 , 2023
Link: https://doi.org/10.1007/..
 
?
11

CSIG-13. CLINICAL IMPACT OF CDKN2A/B DELETIONS IN IDH-MUTAN..:

Yuile, Alexander ; Satgunaseelan, Laveniya ; Alexander, Kimberley L...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii41-vii41 , 2022
Link: https://doi.org/10.1093/..
 
?
12

Determining the Research Priorities for Adult Primary Brain..:

Halkett, Georgia K. B. ; Breen, Lauren J. ; Berg, Melissa...
Current Oncology.  29 (2022)  12 - p. 9928-9955 , 2022
Link: https://doi.org/10.3390/..
 
?
13

Randomised, Phase II study of selumetinib, an oral inhibito..:

Doherty, Mark K. ; Tam, Vincent C. ; McNamara, Mairéad G....
British Journal of Cancer.  127 (2022)  8 - p. 1473-1478 , 2022
Link: https://doi.org/10.1038/..
 
?
14

CTNI-42. GENOME-WIDE DNA METHYLATION PATTERNS IN VERTU: A R..:

Sim, Hao-Wen ; Lwin, Zarnie ; Barnes, Elizabeth...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii81-vii81 , 2022
Link: https://doi.org/10.1093/..
 
?
15

CTIM-24. NUTMEG: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB A..:

Sim, Hao-Wen ; Lwin, Zarnie ; Barnes, Elizabeth...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii65-vii65 , 2022
Link: https://doi.org/10.1093/..
 
1-15